MENU
CRSP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

CRISPR Therapeutics AG (CRSP) Earnings Date & Reports

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

CRSP is expected to report earnings to rise 12.77% to -105 cents per share on November 09

CRISPR Therapeutics AG CRSP Stock Earnings Reports
Q3'26
Est.
$-1.06
Q2'26
Beat
by $0.26
Q1'26
Missed
by $0.05
Q4'25
Missed
by $0.20
Q3'25
Beat
by $0.09
The last earnings report on August 03 showed earnings per share of -93 cents, beating the estimate of -120 cents. With 691.27K shares outstanding, the current market capitalization sits at 4.98B.